The third component of complement (C3) 
glycoprotein that is essential for opsonization of microorganisms, generation of anaphylatoxic activities, and the assembly of the membrane attack complex by either the classical or alternative pathways (4) . In the human, its plasma concentration is the highest of any complement component (150-300 mg/ 100 ml) and is regulated as an acute phase reactant. C3 is synthesized as a single-chain precursor protein (proC3) of -200 kD, which subsequently undergoes signal peptide cleavage and proteolytic cleavage by a plasminlike enzyme to its native two-chain form (5, 6) . Although the hepatocyte is the primary source of plasma C3, studies of C3 synthesis by monocytes from C3-deficient individuals (7) and synovial tissue from patients with rheumatoid arthritis (8) suggested that regulation of C3 synthesis is independent in monocytes and hepatocytes and that mononuclear phagocyte production of C3 plays a significant role in controlling tissue concentrations of this protein.
Lipopolysaccharide (LPS), a constituent ofcell walls ofgramnegative bacteria, is a potent activator of humoral and cellular immunity (9, 10) . Structurally, LPS consists of two polysaccharide moieties (the core polysaccharide and 0 antigen polysaccharide) covalently linked to a lipid region (lipid A). While the polysaccharide portion of the molecule is extremely immunogenic, the lipid portion elicits most of the other biologic effects of LPS. In mononuclear phagocytes, LPS enhances tumoricidal capacity (I 1) and increases production ofsuperoxide anion (12) , hydrolytic enzymes (13) , fibroblast growth factors (14) , prostaglandin E2 (15), and factor B synthesis (FB) (16, 17) . The hydroxymyristate moiety at position two of the lipid A precursor, lipid X, has recently been shown to be a structural requirement for the enhancement ofcytotoxic capacity and prostaglandin E2 production in mouse macrophages (15).
Using incorporation of radiolabeled amino acids into C3 protein detected by gel diffusion, Thorbecke et al. (18) demonstrated originally that the production ofC3 in liver fragments (probably hepatocytes) was increased by injection of adult mice or monkeys with LPS 6-24 h before collection of the livers. More recently, the effect of LPS on complement production by macrophages has been studied by three groups. Miyama et al. (16) B4 by the Westphal procedure was used to avoid the potential effects of lipid A-associated protein in materials extracted by the TCA procedure. Lipid A-inactivated LPS was generated by mild alkaline hydrolysis (20) . Purified lipid X (21) was the generous gift of Christian R. H. Raetz (Dept. of Biochemistry, University of Wisconsin, Madison, WI). Before incubation with monocyte monolayers, all LPS preparations were diluted in LPS-free phosphate-buffered saline (PBS) (by limulus assay, sensitive to 0.01 ng LPS/ml), sonicated, and diluted into tissue culture media that contained between 0.1 and I ng/ml of LPS.
Cell cultures, biosynthetic labeling, and immunoprecipitation. Monocyte monolayers were established and maintained by either of two previously described methods (22, 23) . The effects of LPS were similar on monolayers established by either method. Monolayers were incubated at 370C with LPS in serum-free medium or in medium that contained 5% heat-inactivated (30 min at 560C) autologous serum. Inclusion of heat-inactivated (120 min at 560C) fetal bovine serum (Hazleton Dutchland, Inc., Denver, PA, or Flow Laboratories, McLean, VA) during incubation with LPS abrogated the effect of LPS on C3 synthesis. For most experiments, monolayers maintained for 7 d in culture were used. Cell number was determined by counting nuclei as previously described (24) , and cell viability assessed by measuring lactate dehydrogenase release (25) . Biosynthetic labeling experiments were performed by incubating monocyte monolayers at 370C in methionine-free medium (Dulbecco's modified Eagle's medium 80-0072; Gibco Laboratories, Grand Island, NY) containing [35S]methionine (500 MCi/ml) (specific radioactivity -1,000 Ci/mmol, New England Nuclear, Boston, MA) for 60 min (26) .
At the end of the pulse period, monolayers were rinsed and either lysed by freeze thawing as previously described (26) or, in pulse-chase experiments, transferred to medium containing -1000-fold excess of cold methionine and incubated for varying time periods (chase periods). At the end of each chase interval, extracellular media were harvested and monolayers lysed. Total protein synthesis was estimated by trichloroacetic acid precipitation of aliquots of lysates (27) . Incorporation of [35S]methionine into C3 protein was dependent upon concentration of radiolabeled amino acid from 50 MCi/ml to 500 MCi/ml in the medium in both LPS and control monolayers. When LPS was added to control lysate, no difference in the recovery of radiolabeled C3 protein was observed. Cell lysates and media were immunoprecipitated with excess specific antibody using excess formalin fixed S. aureus (Cowan strain 2, IgGsorb, The Enzyme Center, Malden, MA) as previously described (26) . IgG fractions of goat antisera to C3, FB, and lysozyme were obtained from Atlantic Antibody, Westbrook, ME, and sheep antiserum to human C2 from Seward Laboratory, London, England. Immunoprecipitates were subjected to SDS-polyacrylamide gel electrophoresis, and the resulting gels fixed, impregnated with Enhance (New England Nuclear), dried, and exposed at -70°C to Kodak XAR-5 film (Eastman Kodak Co., Hemolytic titration of C3. Hemolytically active C3 was detected in serum-free media as previously described (23) . Using these methods, as few as 106 molecules of C3 or -20 ng of C3 protein can be detected. The sensitivity and specificity of the hemolytic titration of C3 were not affected by LPS.
Isolation ofC3 complementary DNA (cDNA) clones. Approximately 5 X I04 clones of an adult human liver cDNA library (29) were plated on 82-mm nitrocellulose filters and screened by a modification of the procedure ofGrunstein and Hogness (30) using a mouse C3 cDNA clone (the generous gift of Dr. Morinobu Takahashi, Kanazawa University, Kanazawa, Japan). The mouse C3 cDNA insert was radiolabeled by nick translation (31) and hybridized with filter-bound DNA under standard conditions (32). After hybridization, filters were washed in 30 mM sodium chloride/3 mM sodium citrate at 650C for 1 h, dried, and exposed to Kodak XAR-5 film (Eastman Kodak Co.). Of over 100 positive hybridization signals, eight clones were selected, colony purified, and plasmid DNA was prepared (33). The insert from the largest clone, pC3ALl, was excised with Pstl. The pC3ALl insert has an internal Pstl site and comprises two fragments of -600 and -300 base pairs (bp). The 600-bp fiagment was cloned into the Ml13 vector mpl 1, and nucleotide sequence was determined by the dideoxy chain termination procedure of Sanger et al. (34) . Using sequence homology to the published sequence of murine C3 (35) , this fragment of pC3ALl was found to encompass C3 alpha chain coding sequence from amino acid residue 279 to amino acid residue 479, which includes the thiol ester portion ofthe molecule and was used for all experiments described in this report.
RNA extraction, oligo dTchromatography, andNorthern blot analysis. For RNA extraction, monolayers were established in 100-mm siliconized, glass Petri dishes. Total cellular RNA was extracted from monolayers by lysis with guanidinium thiocyanate and cesium chloride density gradient ultracentrifugation (36) . From 1 to 1.5 ,ug of RNA were isolated from 10' adherent monocytes, and no difference in recovery of RNA between LPS-treated and control monolayers was observed. Poly A+ RNA was purified from equal amounts of total cellular RNA (usually 100-200 Mg) using oligo(dT)-cellulose (type 7, P-L Biochemicals, Inc., Milwaukee, WI), and subjected to Northern blot analysis (37) using single stranded (Ml 3 mpl 1) cDNA probes radiolabeled by primer extended synthesis in the presence of32P-nucleotides (dCTP, dATP, dGTP, dTTP, specific radioactivity -667 Ci/mmol, New England Nuclear). The isolation and characterization of the cDNA probes for C2 (pC2-F2) (38) and FB (pBfA28) (29) have been previously described. Each of these probes has an internal Pstl site. The larger portion of each probe (for C2-F2, 1,200 bp, for pBfA28, 1,900 bp) was subcloned into the singlestranded vector Ml 3 mp 11, and nucleotide sequence was determined by the dideoxy chain termination procedure ofSanger et al. (34) to verify that neither probe was altered during subcloning.
Results
Effect ofLPS on the synthesis and secretion ofC3, C2, FB, and lysozyme in human monocytes. To determine the effect of LPS on C3 production, monocyte monolayers from three individuals were incubated in the presence of 10 ng/ml to 1,000 ng/ml of LPS for 2 d, and hemolytically active C3 in the media was measured. LPS increased C3 production in a concentration dependent fashion (Fig. 1) without causing significant changes in cell number (Table I) or viability. An eightfold variation in C3 production was noted in monocyte monolayers from different donors. Variability in enhancement in C3 production was not a function of the LPS preparation used but was rather a function of variability in response among donors.
To determine whether increased production of C3 resulted from a change in the secretion rate of C3, a change in the synthesis rate of C3, or both, biosynthetic labeling studies using [35S]methionine were performed. The effect of LPS (500 ng/ml for 24 h) on secretion and/or intracellular catabolism was determined by the rate of disappearance of intracellular proC3 in a chase period after a 1-h pulse with [35S]methionine (Fig. 2) . The time required for disappearance of proC3 was slightly delayed in LPS-treated monolayers. Thus, differences in kinetics of secretion could not account for the severalfold increase in C3 recovered in medium from LPS-treated monolayers. In experiments to determine the effect of LPS on C3 synthesis, cells were incubated at 37°C with LPS (500 ng/ml) for 24 h and then pulsed for 1 h with [35Slmethionine. In 10 experiments, LPS-treated cells synthesized 5-30-fold more proC3 (mean 17.9) than the controls (Table I) . Increases in C3 protein in extracellular media were similar when determined either immunochemically or functionally, indicating that no increase in C3 specific functional activity occurred after incubation with LPS (Fig. 3) . Synthesis of C2, lysozyme, and total protein was not affected (Table I and Fig. 3 ). Synthesis of FB was increased from 2-to 55-fold. The increase in the synthesis rate of C3 was detectable between 4 and 8 h after the start of the incubation with LPS and continued to increase through 48 h of incubation with LPS (data not shown). The LPS-induced increase in synthesis of C3 persisted for 48 h after removal of LPS. Monocyte monolayers from freshly adherent cells as well as tissue macrophages (freshly isolated from breast milk) responded to LPS (Fig. 4) .
To determine the biosynthetic steps at which this increase was predominantly regulated, poly A+ RNA was isolated from monocyte monolayers incubated in the presence and absence of LPS and subjected to Northern blot analysis using human cDNA probes for C3, C2, and FB. Using soft laser densitometry, a 4.8-fold increase in C3 mRNA was observed in the LPS-treated monocytes, with a 2.5-fold increase in FB mRNA and a 1.8-fold increase in C2 mRNA (Fig. 5) .
Structural requirementfor the effect ofLPS on human monocyte C3 synthesis. To determine which portion of the LPS molecule was necessary for enhancement of C3 synthesis in human monocytes, the effects of distinct portions of the LPS molecule were examined. First, the lipid portion of the LPS molecule (lipid A) was inactivated by mild alkaline hydrolysis (20) . Lipid A inactivation was documented by the failure ofthis preparation to stimulate mitogenesis in mouse spleen cells. Lipid A-inactivated LPS (500 ng/ml, -5 X 10-8 M) failed to enhance C3 synthesis (Fig. 6) . Secondly, LPS from a polysaccharide-deficient mutant of S. minnesota (500 ng/ml, -5 X 10-8 M) increased C3 synthesis to the same extent as intact LPS (Fig. 6) . Thirdly, lipid X, an acylated monosaccharide thought to be a precursor of lipid A, was used at concentrations from 500 to 4,500 ng/ml (-7 X 10-7-7 X 10-6 M). Lipid X increased C3 production in a concentration-dependent fashion (Fig. 6 ). The molar amounts required for this effect were between 7-and 75-fold greater than with LPS alone.
Discussion
We report that the lipid A portion ofthe LPS molecule stimulates C3 synthesis in primary monolayer cultures of human mononuclear phagocytes at a pretranslational level. The increase in C3 synthesis was specific, in that it occurred without a comparable effect on total protein synthesis or on synthesis of C2 or lysozyme. The increase in FB synthesis was similar to the effect of LPS on FB synthesis in mouse macrophages (17) .
In several previous studies, in vitro and in vivo regulation of C3 production have been examined. Thorbecke et al. (18) first noted C3 synthesis by macrophages using rat peritoneal cells, and suggested that hydrocortisone modulated C3 synthesis. Using a well differentiated rat hepatoma cell line, Strunk et al. (500 ng/ml); 3, lipid X, 500 ng/ml; 4, lipid X, 1,500 ng/ ml; 5, lipid X, 4,500 ng/ml; 6, alkaline-treated LPS; 7, control; 8, E. coli 0 1 1 :B4 LPS (500 ng/ ml); 9, S. minnesota wild type LPS (500 ng/ml); 10, S. minnesota polysaccharide-deficient mutant.
(39) extended these observations when they observed a ninefold increase in functional C3 production in cells exposed to 4 X 10-7 M hydrocortisone. In that study, hydrocortisone specifically enhanced C3 production (production of C2 and C5 was not affected), an observation that suggested that C3 production is regulated independently from other complement proteins. More recently, in vivo activation of guinea pig macrophages by C. parvum resulted in increased C3 production (40) . Although C3 production was modulated by different stimuli, the specific biosynthetic steps at which regulation occurs have not been determined in these studies.
LPS elicits a wide range of biologic responses in whole animals, including shock, increased resistance to infection, and fever (9, 10) . LPS also elicits several cellular responses, including initiation of B lymphocyte proliferation (10) and activation of macrophages, as indicated by release of superoxide anion ( 12) , prostaglandins (41), interleukin-1 (42), neutral proteases (13, 43) , and monocyte-derived fibroblast growth factors (14) . In addition, LPS stimulates several complex macrophage functions, including phagocytosis (44) and tumor cell killing (1 1). The molecular mechanisms that regulate cellular responses to LPS are not well understood, although the molecular biology of several ofthese mechanisms has been explored in vitro and in vivo. For example, when the murine B cell tumor line, BCL1, is stimulated by LPS, regulation of the membrane and secreted forms of the ,u-chain of IgM occurs at both transcriptional and translational levels (45) . The transcriptional activation by LPS of kappa immunoglobulin genes in a B cell lymphoma line, 70Z/3, was accompanied by the appearance of a DNAse I hypersensitive site near a putative enhancer element (46) . LPS also induced production of metallothionein-I mRNA in vivo in livers and kidneys of mice (47 There are several areas noted in these studies that require further exploration. First, the increase in C3 production to LPS in eight separate donors (Fig. 1) (51) . The kinetics of the effect of LPS on production ofC3 in monocytes (initiation of the effect between 4 and 8 h) and on B lymphocyte proliferation (stimulation of incorporation of [3H]thymidine between 7 and 14 h) (9) are consistent with a requirement for the production of one or more signals that are then responsible for the ultimate response. Third, it is not clear whether the increased C3 production occurs in all monocytes or in only a subpopulation. This question is of interest because ofthe possibility that LPS might stimulate C3 synthesis by increasing the amount of C3 synthesized per C3 producing cell, by increasing the number of C3 producing cells, or both. Such a mechanism might account for the differences in effects of LPS on C3 and C2 synthesis: subpopulations of cells that synthesize C2 (26) might be unresponsive to LPS. In situ hybridization with 32P-labeled or biotinylated cDNA probes for the proteins in question may provide an approach to this question. Finally, the significance of the increase in C2 mRNA in LPS-treated monolayers is unclear. It is possible that the difference between the effect of LPS on synthesis of C2 protein and the effect on C2 mRNA content represents control of C2 protein synthesis at the translational level.
The concentrations of LPS used in this study are comparable with those that elicit other effects on macrophages (14, 15) and are severalfold less than those previously used to activate lymphocytes (9, 10) . The physicochemical form of LPS (e.g., in micelles or in membranes) and other lipophilic substances (e.g., high density lipoproteins) may modify the response of human mononuclear phagocytes by altering LPS availability to the cells. Our studies suggest that increased production of C3 by macrophages in tissues colonized or infected with gram-negative organisms may play a role in both tissue regulation of local C3 concentrations and enhanced responsiveness ofthe infected host.
